Fatal intoxication with antidepressants: a case with many culprits

Forensic Science, Medicine, and Pathology
Antonis GoulasAndroniki Tsepa

Abstract

Serotonin-specific reuptake inhibitors (SSRIs) are generally considered safe drugs but fatal adverse effects do sometimes occur, often as a consequence of interactions with other serotonin active drugs. Polypharmacy is usually a problem that the elderly encounter, but it can also have dire consequences for young people, especially when an underlying heart condition is present. Thus, failure to diagnose heart disease and the use of contraindicated medications can be a lethal combination, irrespective of age. Here we present a case of a young adult suffering from bipolar disorder who used a combination of two SSRIs (citalopram and fluoxetine) and a monoamine oxidase inhibitor (MAO; moclobemide) with tragic consequences. The deceased also suffered from undiagnosed hypertrophic cardiomyopathy and was carrier of a genotype that may have predisposed him to increased sensitivity to SSRIs. The apparent difficulty in establishing the manner of death in this case is also discussed.

References

Sep 1, 1989·Journal of Analytical Toxicology·T P Rohrig, R W Prouty
Oct 24, 2000·Journal of Analytical Toxicology·K FuC A Robinson
Apr 13, 2001·Journal of Analytical Toxicology·R DamsA P De Leenheer
Oct 24, 2001·Forensic Science International : Synergy·C L WinekT W Balzer
May 31, 2003·Human & Experimental Toxicology·Anna KoskiErkki Vuori
Jun 3, 2004·Forensic Science International : Synergy·F MusshoffB Madea
Mar 24, 2005·The New England Journal of Medicine·Edward W Boyer, Michael Shannon
Nov 25, 2005·Journal of Pharmacokinetics and Pharmacodynamics·Lena E FribergStephen B Duffull
Dec 2, 2010·International Journal of Legal Medicine·Jennifer L PilgrimOlaf H Drummer
Apr 15, 2011·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·G TalaricoG Bruno
Jul 28, 2012·Critical Care : the Official Journal of the Critical Care Forum·Martin SchulzAchim Schmoldt
Mar 23, 2013·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Jian CaoDawei Li
Jul 25, 2013·Drug Testing and Analysis·Terhi Launiainen, Ilkka Ojanperä
Oct 25, 2013·Drug Metabolism and Pharmacokinetics·Orthodoxia MastrogianniAntonis Goulas
May 2, 2014·Scandinavian Journal of Psychology·Nils Inge Landrø
Mar 6, 2015·Nordic Journal of Psychiatry·Kadri AndreEsa Leinonen
Mar 13, 2016·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Christian J BachmannFalk Hoffmann
Mar 19, 2016·International Journal of Legal Medicine·Ilkka OjanperäErkki Vuori
Dec 19, 2017·Human Psychopharmacology·Georgios PapazisisGeorgios Garyfallos

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Addiction

This feed focuses mechanisms underlying addiction and addictive behaviour including heroin and opium dependence, alcohol intoxication, gambling, and tobacco addiction.

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.